Encyclopedia of Schizophrenia [electronic resource] : Focus on Management Options /
Fleischhacker, W. Wolfgang.editor.
Stolerman, Ian P.editor.
This mini-encyclopedia aims to provide a survey of the wide range of interventions available for treating schizophrenia at a level appropriate for non-specialists who are beginning their engagement in the area and for others as a source of reference for the specialist. The pharmacological options are considered alongside psychosocial management approaches and the advantages and disadvantages of each treatment modality are outlined. The entries are written by leading experts, including basic and clinical scientists in academia and industry, and include descriptions of many relevant fundamental psychological and biological processes of the disorder. The volume owes much to the Encyclopedia of Psychopharmacology edited by Ian Stolerman IP (published by Springer-Verlag in 2010), from which some entries are reproduced. Where entries deal with pharmacological interventions, the aim is to provide detailed information on the neuropsychopharmacology of the substances from domains such as clinical, experimental, and molecular pharmacology, insofar as they impact upon understanding of schizophrenia. Articles on non-drug interventions review the most recent evidence base related to commonly applied psychotherapeutic and rehabilitative measures. Other essays focus upon the key concepts and research methods used in the field, describing the main features of investigative techniques and outlining their roles, the types of information obtained and why they are needed; the advantages and limitations of a technique may also be summarized. The essays are complemented by many short definitions of important terms; in the interest of ease of reading, these definitions are not assigned to named authors; they are typically related to specific essays that they cross-reference and relevant authorship details can be found in the latter.  .
Description based upon print version of record.
Preface; Contents - Schizophrenia Key Essays; Active Avoidance; Aggressive Behavior: Clinical Aspects; Akathisia; Akinesia; Alogia; Aminergic Hypothesis for Schizophrenia; Amisulpride; Angel Dust; Animal Models for Psychiatric States; Anticholinergics; Antipsychotic Drugs; Anti-Parkinson Drugs; Antipsychotic Medication: Future Prospects; Antisaccade Task; Aripiprazole; Asenapine; Atypical Antipsychotic Drugs; Benperidol; Benztropine; Blonanserin; Bradykinesia; Brain Abnormalities; Bromperidol; Butyrophenones; Cariprazine; Carpipramine; Catalepsy; Catatonia; CATIE; Chlorpromazine
Chronic Disappointment ReactionClinical Antipsychotic Trials of InterventionEffectiveness Study; Clocapramine; Clozapine; Cognitive Behavioral Therapy for People withSchizophrenia; Cognitive Impairment; Cognitive Remediation in Schizophrenia Patients; Compliance; CUtLASS; Delayed Onset of Drug Effects; Delusional Disorder; Depot Antipsychotics; Depressive Disorder and Schizophrenia; Dissociative Anesthetics; Dopamine; Dopamine Hypothesis; Dysbindin; Early Ventral Hippocampal Lesion Model; EUFEST; Extrapyramidal Motor Side Effects; Family Based Approaches for SchizophreniaPatients
First-Generation AntipsychoticsFirst-Rank Schizophrenic Symptoms; Floropipamide; Flupenthixol; Functional Outcome; Hallucinations; Hallucinogen Abuse and Dependence; Hallucinogens; Haloperidol; Hypometria; Intramuscular Antipsychotics; Isolation Rearing; K-Hole; Long acting antipsychotics; Lurasidone; Major Tranquilizer; Maternal Deprivation Model; MATRICS; Methamphetamine; Moperone; Mosapramine; Negative Symptoms Syndrome; Nemonapride; Neurodevelopmental Hypothesis; Neurotoxicity and Schizophrenia; New Generation Antipsychotics; Nucleus Accumbens; Olanzapine; Paliperidone; PANSS
Partial AgonistPediatric Schizophrenia; Pericyazine; Perphenazine; Pharmacogenetics of Antipsychotic Drug Response in Schizophrenia; Pharmacogenetics of Drug Side Effects and Safety; Phencyclidine; Phenothiazines; Pimozide; Postpsychotic Depressive Disorder of Schizophrenia; Pre-psychotic States and Prodromal Symptoms; Prochlorperazine; Prolactin; Propranolol; Pseudo-Hallucination; Psychoeducation in the Management ofSchizophrenia; Psychotic Symptoms; Quetiapine; Rating Scales and Diagnostic Schemata; Rehabilitation in Schizophrenia; Reserpine; Risperidone; Schizoaffective Disorder
SchizophreniaSchizophrenia Prodrome; Second and Third Generation Antipsychotics; Striatum; Sulpiride; Tardive Dyskinesia; Thioridazine; Thiothixene; Thioxanthenes; Treatment-Resistant Schizophrenia; Tremor; Trifluoperazine; Trihexyphenidyl; Typical Antipsychotics; Ventral Tegmental Area; Ventromedial Prefrontal Cortex; Ziprasidone
This mini-encyclopedia aims to provide a survey of the wide range of interventions available for treating schizophrenia at a level appropriate for non-specialists who are beginning their engagement in the area and for others as a source of reference for the specialist. The pharmacological options are considered alongside psychosocial management approaches and the advantages and disadvantages of each treatment modality are outlined. The entries are written by leading experts, including basic and clinical scientists in academia and industry, and include descriptions of many relevant fundamental psychological and biological processes of the disorder. The volume owes much to the Encyclopedia of Psychopharmacology edited by Ian Stolerman IP (published by Springer-Verlag in 2010), from which some entries are reproduced. Where entries deal with pharmacological interventions, the aim is to provide detailed information on the neuropsychopharmacology of the substances from domains such as clinical, experimental, and molecular pharmacology, insofar as they impact upon understanding of schizophrenia. Articles on non-drug interventions review the most recent evidence base related to commonly applied psychotherapeutic and rehabilitative measures. Other essays focus upon the key concepts and research methods used in the field, describing the main features of investigative techniques and outlining their roles, the types of information obtained and why they are needed; the advantages and limitations of a technique may also be summarized. The essays are complemented by many short definitions of important terms; in the interest of ease of reading, these definitions are not assigned to named authors; they are typically related to specific essays that they cross-reference and relevant authorship details can be found in the latter.  .
Psychiatry.
Psychopharmacology.
Psychotherapy   .
Clinical psychology.
Psychotherapy.
Counseling.
Psychiatry.
Psychopharmacology.
Psychotherapy.
Clinical Psychology.
Psychotherapy and Counseling.